Selective Laser Trabeculoplasty Services
Selective Laser Trabeculoplasty (SLT) is clinically proven by the LiGHT trial to be a safe and effective first-line therapy for the treatment of primary open angle glaucoma or ocular hypertension1.
-
Most popular related searches
Details
The preferred first-line therapy for glaucoma
Selective Laser Trabeculoplasty (SLT), plays a critically important role in the treatment of glaucoma. Around the world, thousands of physicians are deploying the procedure as a primary therapy tool that stimulates the eye's natural healing response to effectively manage their patients’ IOP without the burn and scar tissue associated with argon laser trabeculoplasty (ALT).
Watch how SLT (Selective Laser Trabeculoplasty), the recommended first-line therapy for glaucoma, gently reduces intraocular pressure.
Reduce IOP — as effectively as medication
SLT is an advanced, non-thermal nanosecond laser treatment that can achieve reductions in IOP as effectively as medication, without the associated side effects or compliance problems.1 SLT is also ideally suited for glaucoma patients who are frustrated with the effectiveness of their medications; it can play a role in reducing their associated financial and lifestyle burdens.
Published in The Lancet, the pivotal results of the LiGHT trial compared the use of SLT versus eye drops as a first-line treatment for treatment-naïve patients who had open angle glaucoma or ocular hypertension – and recommended SLT as first-line treatment for open angle glaucoma and ocular hypertension, supporting a change in clinical practice.”
Customer reviews
No reviews were found for Selective Laser Trabeculoplasty Services. Be the first to review!